Martin Fussenegger: Catalogue data in Autumn Semester 2023

Name Prof. Dr. Martin Fussenegger
FieldBiotechnologie und Bioingenieurwissenschaften
Address
Dep. Biosysteme
ETH Zürich, BSS F 17.3
Klingelbergstrasse 48
4056 Basel
SWITZERLAND
Telephone+41 61 387 31 60
Fax+41 61 387 39 88
E-mailmartin.fussenegger@bsse.ethz.ch
DepartmentBiosystems Science and Engineering
RelationshipFull Professor

NumberTitleECTSHoursLecturers
636-0102-10LAdvanced Bioengineering
Only for Biotechnologie Master, Programme Regulations 2021 or doctoral students of D-BSSE.
2 credits3SS. Panke, Y. Benenson, P. S. Dittrich, M. Fussenegger, A. Hierlemann, A. Moor, M. Nash, R. Platt, S. Reddy, T. Schroeder, J. Stelling, B. Treutlein
AbstractThis course provides an overview of modern concepts of bioengineering across different levels of complexity, from single molecules to systems, microscaled reactors to production environments, and across different fields of applications
Learning objectiveStudents will be able to recognize major developments in bioengineering across different organisms and levels of complexity and be able to relate it to major technological and conceptual advances in the underlying sciences.
ContentMolecular and cellular engineering; Synthetic biology: Engineering strategies in biology; from single molecules to systems; downscaling bioengineering; Bioengineering in chemistry, pharmaceutical sciences, and diagnostics, personalized medicine.
Lecture notesHandouts during class
LiteratureWill be announced during the course
CompetenciesCompetencies
Subject-specific CompetenciesConcepts and Theoriesassessed
Techniques and Technologiesassessed
Personal CompetenciesCritical Thinkingassessed
636-0108-00LBiological Engineering and Biotechnology4 credits3VM. Fussenegger
AbstractBiological Engineering and Biotechnology will cover the latest biotechnological advances as well as their industrial implementation to engineer mammalian cells for use in human therapy. This lecture will provide forefront insights into key scientific aspects and the main points in industrial decision-making to bring a therapeutic from target to market.
Learning objectiveBiological Engineering and Biotechnology will cover the latest biotechnological advances as well as their industrial implementation to engineer mammalian cells for use in human therapy. This lecture will provide forefront insights into key scientific aspects and the main points in industrial decision-making to bring a therapeutic from target to market.
Content1. Insight Into The Mammalian Cell Cycle. Cycling, The Balance Between Proliferation and Cancer - Implications For Biopharmaceutical Manufacturing. 2. The Licence To Kill. Apoptosis Regulatory Networks - Engineering of Survival Pathways To Increase Robustness of Production Cell Lines. 3. Everything Under Control I. Regulated Transgene Expression in Mammalian Cells - Facts and Future. 4. Secretion Engineering. The Traffic Jam getting out of the Cell. 5. From Target To Market. An Antibody's Journey From Cell Culture to The Clinics. 6. Biology and Malign Applications. Do Life Sciences Enable the Development of Biological Weapons? 7. Functional Food. Enjoy your Meal! 8. Industrial Genomics. Getting a Systems View on Nutrition and Health - An Industrial Perspective. 9. IP Management - Food Technology. Protecting Your Knowledge For Business. 10. Biopharmaceutical Manufacturing I. Introduction to Process Development. 11. Biopharmaceutical Manufacturing II. Up- stream Development. 12. Biopharmaceutical Manufacturing III. Downstream Development. 13. Biopharmaceutical Manufacturing IV. Pharma Development.
Lecture notesHandout during the course.
636-0309-00LAdvances in Molecular Biotechnology2 credits2SM. Fussenegger
AbstractThis seminar features the latest progress in molecular biotechnology, including topics from bioengineering, synthetic biology as well as gene- and cell-based therapies.
Learning objectiveTo provide an overview of current strategies to engineer mammalian cells.